Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. [electronic resource]
Producer: 20110419Description: 26-36, 1 p. digitalISSN:- 1476-5578
- Adult
- Analysis of Variance
- Atrophy -- drug therapy
- Attention -- drug effects
- Brain -- drug effects
- Double-Blind Method
- Erythropoietin -- administration & dosage
- Humans
- Male
- Memory -- drug effects
- Middle Aged
- Neuroprotective Agents -- administration & dosage
- Recombinant Proteins
- Schizophrenia -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.